Contineum Therapeutics, Inc. (CTNM) › Shares OutstandingContineum Therapeutics, Inc. (CTNM) — Shares OutstandingAnnual figures by fiscal year, from SEC filings.2023: 3.40M2024: 19.35M2025: 27.70M27.70M2023Shares Outstanding (shares)2025Fiscal YearShares OutstandingChange YoY202527.70M+43.1%202419.35M+470.0%20233.40M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per Share